Warning: September Asthma Spike Ahead
22 août 2024 07h00 HE
|
Asthma and Allergy Foundation of America
Washington, DC, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) today warned about a combination of factors coming together to make September the worst month of...
Acute Respiratory Distress Syndrome Analysis Report 2024: A $2.36 Billion Market by 2032 from $1.23 Billion in 2023
18 juil. 2024 06h27 HE
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome Market Report by Type, End User, Regions and Company Analysis 2024-2032" report has been added to ...
Bronchiectasis Opportunity Assessment and 10 Year Forecast 2023-2033
06 juin 2024 09h09 HE
|
Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Bronchiectasis: Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering. This report covers the 8 Major...
Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference
22 mai 2024 11h15 HE
|
Upstream Bio, Inc.
Positive results from a Phase 1 dose ranging study of verekitug (UPB-101) in asthma presented at ATS 2024
Upstream Bio to Present Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society (ATS) International Conference
15 mai 2024 07h00 HE
|
Upstream Bio, Inc.
Upstream Bio will present clinical data from dose-ranging study of verekitug (UPB-101) in adults with asthma at the American Thoracic Society conference
Green Ribbon Panel Unveils New Policy Recommendations for Green Economic Growth on World Asthma Day
07 mai 2024 13h12 HE
|
Green Ribbon Panel
The Green Ribbon Panel launched its new report advancing policy recommendations that keep Canadians’ air clean while also supporting economic growth.
AAFA Co-Hosts Congressional Briefing Highlighting 25th Year of National Asthma Control Program
07 mai 2024 07h00 HE
|
Asthma and Allergy Foundation of America
Washington, DC, May 07, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is celebrating the 25th year of the CDC’s National Asthma Control Program (NACP) on World Asthma...
Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update
07 mai 2024 04h09 HE
|
AKAMPION
Geneva (Switzerland), May 7, 2024 – Atopia Therapeutics, a leader in the development of breakthrough asthma and allergy therapies, today announced the appointment of Dr. Grégoire Chevalier as Chief...
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
02 mai 2024 08h00 HE
|
Science 37, Inc.
Science 37's Metasite™ and Patient Recruitment Solutions together dramatically boost patient enrollment in a Phase 3 asthma clinical trial.
National Asthma and Allergy Awareness Month Empowers Individuals and Communities
30 avr. 2024 10h22 HE
|
Asthma and Allergy Foundation of America
Washington, DC, April 30, 2024 (GLOBE NEWSWIRE) -- Since 1984, the Asthma and Allergy Foundation of America (AAFA) has designated May as National Asthma and Allergy Awareness Month. This year, AAFA...